| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |